TherapeuticsMD, Inc. — Director's Dealing 2014

Mar 10, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2014-03-07

Reporting Person: Milligan John C.K. IV (Director, President and Secretary)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-03-07	Common Stock	G	300000	—	Disposed	1722419	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4245599	Indirect

Footnotes

F1: Excludes 4,245,599 shares of common stock of TherapeuticsMD, Inc. previously owned directly, which were contributed to the John C.K. Milligan Revocable Trust dtd 08/10/2009, as amended, on March 7, 2014.

F2: By John C.K. Milligan Revocable Trust dtd 08/10/2009, as amended.